1. Home
  2. EARN vs ACHV Comparison

EARN vs ACHV Comparison

Compare EARN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

N/A

Current Price

$5.28

Market Cap

189.7M

Sector

Real Estate

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.36

Market Cap

239.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
ACHV
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
239.0M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
EARN
ACHV
Price
$5.28
$4.36
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$5.88
$15.50
AVG Volume (30 Days)
323.8K
598.8K
Earning Date
02-20-2026
11-06-2025
Dividend Yield
18.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,893,000.00
N/A
Revenue This Year
$8.43
N/A
Revenue Next Year
$17.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.30
N/A
52 Week Low
$4.33
$1.84
52 Week High
$6.86
$5.78

Technical Indicators

Market Signals
Indicator
EARN
ACHV
Relative Strength Index (RSI) 52.63 44.93
Support Level $5.15 $4.23
Resistance Level $5.34 $4.86
Average True Range (ATR) 0.09 0.26
MACD 0.00 -0.06
Stochastic Oscillator 60.18 8.85

Price Performance

Historical Comparison
EARN
ACHV

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: